Erratum: Obesity changes the human gut mycobiome (Scientific Reports (2016) 5 (14600) DOI: 10.1038/srep14600);Obesity changes the human gut mycobiome

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Mar Rodriguez M ^a   Pérez, Daniel ^b   Javier Chaves, Felipe ^b   Esteve, Eduardo ^a   Marin Garcia, Pablo ^b   Xifra, Gemma ^a   Vendrell, Joan ^c   Jové, Mariona ^d   Pamplona, Reinald ^d   Ricart, Wifredo ^a   Portero Otin, Manuel ^d   Chacón, Matilde R ^c   Fernández Real, José Manuel ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^c HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^d UNIVERSITY OF LLEIDA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE BLOOD LEVEL; GLUTAMIC ACID DERIVATIVE; HEXADECANEDIOIC ACID; HEXANOIC ACID; HEXANOIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; N-ACETYLGLUTAMIC ACID; PALMITIC ACID DERIVATIVE; SPACER DNA; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ADULT; ASPERGILLUS; BLOOD; CANDIDA; CASE CONTROL STUDY; CLASSIFICATION; DIET RESTRICTION; DNA SEQUENCE; FEMALE; GENETICS; GLUCOSE BLOOD LEVEL; GROWTH, DEVELOPMENT AND AGING; HUMAN; INTESTINE; INTESTINE FLORA; MALE; METABOLISM; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; MUCOR; OBESITY; PATHOLOGY; PENICILLIUM; SACCHAROMYCES;

ADIPOSE TISSUE; ADULT; ASPERGILLUS; BLOOD GLUCOSE; CANDIDA; CAPROATES; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; DNA, INTERGENIC; FASTING; FEMALE; GASTROINTESTINAL MICROBIOME; GLUTAMATES; HUMANS; INTESTINES; MALE; MIDDLE AGED; MUCOR; MYCOLOGICAL TYPING TECHNIQUES; OBESITY; PALMITIC ACIDS; PENICILLIUM; SACCHAROMYCES; SEQUENCE ANALYSIS, DNA; TRIGLYCERIDES;

EID: 84943768015     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep21679     Document Type: Erratum

References (37)

1. Devaraj, S., Hemarajata, P., Versalovic, J. The human gut microbiome and body metabolism: implications for obesity and diabetes. Clin. Chem. 59, 617-28 (2013).
2. Ma, J. et al. High-fat maternal diet during pregnancy persistently alters the offspring microbiome in a primate model. Nat. Commun. 5, 3889 (2014).
3. Underhill, D. M., Iliev, I. D. The mycobiota: interactions between commensal fungi and the host immune system. Nat. Rev. Immunol. 14, 405-16 (2014).
4. Turnbaugh, P. J. et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027-31 (2006).
5. Le Chatelier, E. et al. Richness of human gut microbiome correlates with metabolic markers. Nature 500, 541-6 (2013).
6. Greiner, T., Bkhed, F. Effects of the gut microbiota on obesity and glucose homeostasis. Trends Endocrinol. Metab. 22, 117-23 (2011).
7. Suez, J. et al. Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature (2014). doi: 10.1038/nature13793
8. Qin, J. et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 59-65 (2010).
9. Scanlan, P. D., Marchesi, J. R. Micro-eukaryotic diversity of the human distal gut microbiota: qualitative assessment using culture-dependent and-independent analysis of faeces. ISME J. 2, 1183-93 (2008).
10. Arumugam, M. et al. Enterotypes of the human gut microbiome. Nature 473, 174-80 (2011).
11. Huffnagle, G. B., Noverr, M. C. The emerging world of the fungal microbiome. Trends Microbiol. 21, 334-41 (2013).
12. Hamad, I., Sokhna, C., Raoult, D., Bittar, F. Molecular detection of eukaryotes in a single human stool sample from senegal. PLoS One 7, e40888 (2012).
13. Chen, Y. et al. Correlation between gastrointestinal fungi and varying degrees of chronic hepatitis B virus infection. Diagn. Microbiol. Infect. Dis. 70, 492-8 (2011).
14. Mukherjee, P. K. et al. Mycobiota in gastrointestinal diseases. Nat. Rev. Gastroenterol. Hepatol. 1-11 (2014), doi: 10.1038/nrgastro.2014.188
15. Hoffmann, C. et al. Archaea and Fungi of the Human Gut Microbiome: Correlations with Diet and Bacterial Residents. PLoS One 8, e66019 (2013).
16. Iliev, I. D. et al. Interactions Between Commensal Fungi and the C-Type Lectin Receptor Dectin-1 Influence Colitis. Science (80 .).336, 1314-1317 (2012).
17. Ott, S. J. et al. Fungi and inflammatory bowel diseases: Alterations of composition and diversity. Scand. J. Gastroenterol. 43, 831-41 (2008).
18. Li, Q. et al. Dysbiosis of Gut Fungal Microbiota is Associated With Mucosal Inflammation in Crohn's Disease. J. Clin. Gastroenterol. 48, 513-23 (2014).
19. Verdam, F. J. et al. Human intestinal microbiota composition is associated with local and systemic inflammation in obesity. Obesity (Silver Spring).21, E607-15 (2013).
20. Lee, D.-S. et al. PTP1B inhibitory and anti-inflammatory effects of secondary metabolites isolated from the marine-derived fungus Penicillium sp. JF-55. Mar. Drugs 11, 1409-26 (2013).
21. Hoare, D. S., Hoare, S. L., Brame, J. O. E. Deacetylation of N-Acetyl-L-Glutamic Acid by Neurospora crassa. 94, 782-783 (1967).
22. Hofbauer, K. G. et al. CGP22979A a Renal Vasodilator with Natriuretic. J. Pharmacol. Exp. Ther. 232, 838-844 (1985).
23. Brasch, J., Friege, B. Dicarboxylic acids affect the growth of dermatophytes in vitro. Acta Derm. Venereol. 74, 347-350 (1994).
24. Gosiewski, T. et al. Quantitative evaluation of fungi of the genus Candida in the feces of adult patients with type 1 and 2 diabetes-a pilot study. Gut Pathog. 6, 43 (2014).
25. Cui, L., Morris, A., Ghedin, E. The human mycobiome in health and disease. Genome Med. 5, 63 (2013).
26. Standaert-Vitse, A. et al. Candida albicans colonization and ASCA in familial Crohn's disease. Am. J. Gastroenterol. 104, 1745-53 (2009).
27. Karimi, K., Zamani, A. Mucor indicus: biology and industrial application perspectives: a review. Biotechnol. Adv. 31, 466-81 (2013).
28. Walsh, A. M., Sweeney, T., Bahar, B., O'Doherty, J. V. Multi-functional roles of chitosan as a potential protective agent against obesity. PLoS One 8, e53828 (2013).
29. Tajdini, F., Amini, M. A., Nafissi-Varcheh, N., Faramarzi, M. A. Production, physiochemical and antimicrobial properties of fungal chitosan from Rhizomucor miehei and Mucor racemosus. Int. J. Biol. Macromol. 47, 180-3 (2010).
30. Ley, R., Turnbaugh, P., Klein, S., Gordon, J. Microbial ecology: human gut microbes associated with obesity. Nature 444, 1022-3 (2006).
31. Shreiner, A. B., Kao, J. Y., Young, V. B. The gut microbiome in health and in disease. Curr. Opin. Gastroenterol. 69-75 (2014). doi: 10.1097/MOG.0000000000000139.
32. Mukherjee, P. K. et al. Oral Mycobiome Analysis of HIV-Infected Patients: Identification of Pichia as an Antagonist of Opportunistic Fungi. PLoS Pathog. 10, e1003996 (2014).
33. Caliski, T., Harabasz, J. A dendrite method for cluster analysis. Commun. Stat. 3, 1-27 (1974).
34. Bernal-Martez L., Buitrago, M. J., Castelli M. V., Castelli, M. V., Rodruez-Tudela J. L., Cuenca-Estrella M. Development of a single tube multiplex real-time PCR to detect the most clinically relevant Mucormycetes species. Clin. Microbiol. Infect. 19, E1-7 (2013).
35. Liu, C. M. et al. FungiQuant: a broad-coverage fungal quantitative real-time PCR assay. BMC Microbiol. 12, 255 (2012).
36. Jov M., Mauri-capdevila, G., Portero-Ot, M. Metabolomics predicts stroke recurrence after transient ischemic attack. Neurology. 84, 36-45 (2014).
37. Xia, J., Mandal, R., Sinelnikov, I. V., Broadhurst, D., Wishart, D. S. MetaboAnalyst 2.0-a comprehensive server for metabolomic data analysis. Nucleic Acids Res. 40, W127-33 (2012).